Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2018) 56 P1070 | DOI: 10.1530/endoabs.56.P1070

1UGC Endocrinology and Nutrition, Hospital Reina Sofía, Córdoba, Spain; 2UGC Endocrinology and Nutrition, Hospital Universitario Reina Sofía, Córdoba, Spain; 3UCG Radiodiagnosis. Hospital Reina Sofía, Córdoba, Spain.


Introduction: Fine-needle aspiration (FNA) is indicated in suspicious thyroid nodules or big ones. Bethesda system classifies them according to the cytological malignancy risk. Bethesda category 4 (B4) comprises follicular neoplasms and suspicious follicular neoplasms. Aim: Determine final diagnosis of B4 nodules and study associations between malignancy and other variables.

Methods: Retrospective study of patients with nodules classified as B4 after FNA in our hospital between 2013 and 2017. Statistical analysis: SPSS v.19.0 (Student’s t test to compare means and χ2/Fisher’s test for proportions).

Results: 141 patients, 73.8% women, mean age: 53.33±14.90. 76.6% evaluated by the Endocrinology service prior to the FNA (21.3% previous thyroid pathology; 87.2% normal function). Symptoms: 88.7% asymptomatic. 5.7% cervical pain, 3.5% dysphonia, 3.5% dysphagia. Nodule discovery: 49.6% accidentally discovered in imaging studies done for other reasons, 35.5% palpation, 8.5% symptoms related to the nodule and 6.4% in routine follow-up sonography (US). Sonography characteristics: maximum diameter: 30.93±16.88 mm. 82.3% solid, 56.7% hypoechoic, 30.5% hypervascular, 9.2% coarse calcifications, 4.3% suspicious adenopathies and 1.4% microcalcifications (In the US 9.9% suspicious, 11.3% non-suspicious, 78.8% undetermined). 20.5% of them with previous FNA (1.4% B2, 7.8% B1, 11.2% B3). 84.4% patients underwent surgery (39.5% total thyroidectomy), 114.54±84.97 days after FNA. Final diagnosis: 77.3% benign (73.9% adenoma, 15.2% noninvasive follicular thyroid neoplasm with papillary-like nuclear features [NIFTP], 10.9% nodular goiter) and 22.7% malignant (51.9% follicular carcinoma, 40.7% papillary carcinoma, 7.4% medullary carcinoma). Most prevalent diagnosis after surgery: 33.6% folicular adenoma, 21.8% Hürthle adenoma, 11.8% NIFTP. Incidental microcarcinoma in 12.6% of interventions. Association with malignancy: Cervical pain (1.8 vs 20%, P=0.010), bigger maximum diameter (15.88±1.72 vs 18.27±3.23 mm, P=0.009). Tendency to association with malignancy: microcalcifications (0 vs 7.1%, P=0.068), hypoechogenicity (65.3 vs 89.5%, P=0.076).

Conclusions: 1) Incidentally discovered nodules equals clinically discovered ones.

2) Prevalence of malignancy in nodules classified as B4 is similar to the one reported in previous publications.

3) There is a statistically significative association between malignancy and clinical finding (cervical pain) and sonographic findings (bigger nodule size), as previously reported in the literature.

Volume 56

20th European Congress of Endocrinology

Barcelona, Spain
19 May 2018 - 22 May 2018

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.